Using donor hearts from patients who died of traumatic brain injury might be a more viable option for transplant candidates than previously thought, according to an analysis published in the Journal of the American Heart Association Aug. 30.
KentuckyOne Health is nixing its month-old plan to inactivate its heart transplant program at Jewish Hospital in Louisville, instead opting to work with the University of Louisville to keep the program alive.
A single dose of the lipid-lowerer simvastatin, delivered to an organ donor pre-heart transplant, could decrease postoperative troponin levels in transplant recipients and protect the donor heart against perioperative myocardial ischemic damage.
The FDA has expanded its indication for TAVR to low-risk patients, the agency announced August 16, approving a handful of valves for an intervention that was previously limited to intermediate- and high-risk patients.
Compared to on-pump CABG, off-pump surgery is associated with lower rates of revascularization and a significantly increased risk of all-cause death at three years, according to an analysis of the EXCEL trial.
The director of Duke University’s heart transplant program is promoting warm perfusion—a technique that preserves organs more effectively than a traditional cooling box—as a means of expanding the CV donor pool in the U.S.
A federal review of UNC Hospital’s pediatric cardiology unit found “no current deficiencies” in the program just two months after the New York Times published an article suggesting the unit was in “total disarray."